RELAY THERAPEUTICS INC
NASDAQ: RLAY (Relay Therapeutics, Inc.)
Last update: 17 hours ago14.81
0.57 (4.00%)
| Previous Close | 14.24 |
| Open | 14.21 |
| Volume | 1,770,119 |
| Avg. Volume (3M) | 3,707,147 |
| Market Cap | 3,227,696,384 |
| Price / Sales | 241.55 |
| Price / Book | 5.02 |
| 52 Weeks Range |
| Operating Margin (TTM) | -1,105.21% |
| Diluted EPS (TTM) | -2.20 |
| Quarterly Revenue Growth (YOY) | -23.30% |
| Total Debt/Equity (MRQ) | 6.54% |
| Current Ratio (MRQ) | 19.96 |
| Operating Cash Flow (TTM) | -271.99 M |
| Levered Free Cash Flow (TTM) | -155.22 M |
| Return on Assets (TTM) | -28.82% |
| Return on Equity (TTM) | -45.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Relay Therapeutics, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -0.13 |
|
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971). |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 1.48% |
| % Held by Institutions | 105.68% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Nextech Invest, Ltd. | 31 Mar 2026 | 5,526,506 |
| Spruce Street Capital Lp | 31 Mar 2026 | 2,984,125 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |